L

LegoChem Biosciences Inc
KOSDAQ:141080

Watchlist Manager
LegoChem Biosciences Inc
KOSDAQ:141080
Watchlist
Price: 95 500 KRW -1.55% Market Closed
Market Cap: 3.5T KRW
Have any thoughts about
LegoChem Biosciences Inc?
Write Note

LegoChem Biosciences Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

LegoChem Biosciences Inc
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
L
LegoChem Biosciences Inc
KOSDAQ:141080
Cash from Investing Activities
-â‚©439.5B
CAGR 3-Years
-45%
CAGR 5-Years
-67%
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Cash from Investing Activities
-â‚©554.2B
CAGR 3-Years
-126%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Knotus Co Ltd
KOSDAQ:278650
Cash from Investing Activities
â‚©55.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
ST Pharm Co Ltd
KOSDAQ:237690
Cash from Investing Activities
-â‚©22B
CAGR 3-Years
41%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Cash from Investing Activities
â‚©3.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Cash from Investing Activities
â‚©1.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

LegoChem Biosciences Inc
Glance View

Market Cap
3.5T KRW
Industry
Life Sciences Tools & Services

LegoChem Biosciences, Inc. engages in the development, manufacture of medicines, medical devices and medical supplies. The company is headquartered in Daejeon, Daejeon and currently employs 116 full-time employees. The company went IPO on 2013-05-10. The firm principally involves in the development of new drugs, including antibiotics, anticoagulants, anticancer, antiplatelet, anti-inflammatory, as well as antibody-drug-conjugates (ADC), among others. The firm operates its business through technology transfer, joint and contact research and research services.

Intrinsic Value
18 608.03 KRW
Overvaluation 81%
Intrinsic Value
Price
L

See Also

What is LegoChem Biosciences Inc's Cash from Investing Activities?
Cash from Investing Activities
-439.5B KRW

Based on the financial report for Sep 30, 2024, LegoChem Biosciences Inc's Cash from Investing Activities amounts to -439.5B KRW.

What is LegoChem Biosciences Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-67%

Over the last year, the Cash from Investing Activities growth was -12 996%. The average annual Cash from Investing Activities growth rates for LegoChem Biosciences Inc have been -45% over the past three years , -67% over the past five years .

Back to Top